Brief: Aeglea Biotherapeutics Announces Sale Of Pegzilarginase To Immedica Pharma

Spyre Therapeutics

27/07/2023 12:08

July 27 (Reuters) - Aeglea Bio Therapeutics Inc
 AGLE.O :
    * AEGLEA BIOTHERAPEUTICS ANNOUNCES SALE OF PEGZILARGINASE TO
IMMEDICA PHARMA
    * AEGLEA BIO THERAPEUTICS INC - MARKETING AUTHORISATION
APPLICATION FOR PEGZILARGINASE IS UNDER REVIEW BY EUROPEAN
MEDICINES AGENCY
    * AEGLEA BIO THERAPEUTICS INC- MARKETING AUTHORISATION
APPLICATION
FOR PEGZILARGINASE IS UNDER REVIEW BY EUROPEAN MEDICINES AGENCY
    * AEGLEA BIO THERAPEUTICS - GLOBAL RIGHTS TO PEGZILARGINASE
IN
DEVELOPMENT FOR ARGINASE 1 DEFICIENCY SOLD TO IMMEDICA PHARMA
FOR $15 MILLION UPFRONT CASH
    * AEGLEA BIO THERAPEUTICS INC - UP TO $100 MILLION OF
CONTINGENT
MILESTONE PAYMENTS

Source text for Eikon:  ID:nPn4R9QTNa 
Further company coverage:  AGLE.O 

 ((Reuters.Briefs@thomsonreuters.com;))